Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics.[2][3]
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | mRNA |
Clinical data | |
Other names | SW 0123 |
Routes of administration | Intramuscular |
Identifiers | |
CAS Number |
References
edit- ^ "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF).
- ^ "Randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of mRNACOVID-19 vaccine in healthy susceptible populations aged 18 years and older people". Chinese Clinical Trial Registry (ChiCTR). Archived from the original on 15 May 2021. Retrieved 15 May 2021.
- ^ Clinical trial number NCT05144139 for "A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above" at ClinicalTrials.gov